Upload
vanxuyen
View
214
Download
1
Embed Size (px)
Citation preview
Global Conference
Drug Information PRN Focus Session—When Time is of the Essence: Efficiently Finding and Evaluating the Evidence to Make Individual Patient Decisions Activity Number: 0217-0000-15-131-L04-P, 1.50 hours of CPE credit; Activity Type: An Application-Based Activity Tuesday, October 20, 2015 10:15 a.m. to 11:45 a.m. Plaza Room A Moderator: Dianne W. May, Pharm.D., BCPS Clinical Professor, University of Georgia College of Pharmacy and Clinical Pharmacy Specialist, Georgia Regents Medical Center, Augusta, Georgia Agenda
10:15 a.m. Looking Beyond PubMed: Making the Most of Google Power Searching and Use of Grey Literature in Pharmacy Practice
Philip J. Gregory, Pharm.D., MS Director, Center for Drug Information & Evidence-Based Practice, Associate Professor, Pharmacy Practice, Creighton University, Omaha, Nebraska
11:00 a.m. When Time Matters: Innovative Tools and Techniques to Evaluate the
Quality of a Clinical Trial Quickly and Efficiently Melissa M. Blair, Pharm.D., FCCP, FASHP, BCPS
Associate Editor, Therapeutics Research Center, Stockton, California; Pharmacist III, New Hanover Regional Medical Center, Wilmington, North Carolina
Conflict of Interest Disclosures Melissa M. Blair: no conflicts to disclose. Philip J. Gregory: Consultant/member of advisory board for Therapeutic Research Center-Publisher of Pharmacist’s Letter and Natural Medicines Comprehensive Database, and US Antidoping Agency. Dianne W. May: no conflicts to disclose. Learning Objectives
1. Differentiate the value of Google Power Searching compared to a PubMed search in answering drug
information questions that arise in your daily practice. 2. Evaluate the value of grey literature as it might be applied to your clinical practice. 3. Identify other useful resources used to find drug information. 4. Execute a google power search and find grey literature when presented a case-based scenario. 5. Identify essential elements of a clinical trial and practical strategies that can be used by the busy
practitioner for evaluating the evidence. 6. Differentiate key concepts that should be considered based on type of the trial reviewed (e.g., meta-
analysis, randomized-controlled trial, non-inferiority trial, effectiveness trials, etc.) 7. Apply the tools and techniques described to evaluate a clinical trial quickly and efficiently.
© American College of Clinical Pharmacy 1
Global Conference
8. Use strategies discussed to draw conclusions related to quality in daily practice. Self-Assessment Questions
Self-assessment questions are available online at www.accp.com/gc15.
© American College of Clinical Pharmacy 2
Looking Beyond PubMed – Making the Most of Google Power Searching, Grey Literature, and Other Tools
Philip J. Gregory, PharmD, MS, FACNOctober 20, 2015
2015 ACCP Global Conference on Clinical Pharmacy
Conflict of Interests
Consultant Therapeutic Research Center
Learning Objectives
Evaluate the value of grey literature as it isapplied to clinical practice
Differentiate the value of Google PowerSearching and PubMed searching
Identify other useful resources used to finddrug information
Execute a Google Power Search and findgrey literature when presented a case
Grey Literature
Literature that isn’t in a book, journal, orpublished newsletter Not controlled by commercial publishing
Governmental publications
Academic / Business / organizational documents
Print or electronic formats
4th International Conference on Grey Literature, 1999
Grey Literature –Examples Conference abstracts, posters, proceedings
Hospital protocols, reports, monographs
Governmental reports and documents
Theses, Dissertations
Listserv communications
Social media or personal communications
Grey Literature –Where can you find it?
Specialty databases International Pharmaceutical Abstracts (IPA)
Web of Science
Guidelines.gov / Clinicaltrials.gov
Many others
Institutional Repositories
Organizational websites
Search engines (e.g., Google, Bing)
© American College of Clinical Pharmacy 3
Grey Literature –You’re already using it
Drug manufacturer data Package insert / data on file
Medical information communications
FDA documents Safety alerts / recalls
Orange book, Purple book
Drugs@FDA
Hospital Protocols
PRN Communications
Grey Literature –You’re already using it
Organizational websites Treatment guidelines
Health statistics
Position papers
CDC website Immunization schedules
Guidelines / statistics
Some favorites…VA Pharmacy Benefits Management Services (www.pbm.va.gov/PBM/)
Some favorites…FDAble (www.fdable.com)
Some favorites…Canada Vigilance Adverse Reaction Database (webprod3.hc-sc.gc.ca/arquery-rechercheei/index-eng.jsp)
Some favorites…AHRQ Evidence-Based Practice Center Reports(http://www.ahrq.gov/research/findings/evidence-based-reports/a-z/index.html)
© American College of Clinical Pharmacy 4
Grey Literature
Advantages Abundant
Complementary to published literature Fills in gaps
Cutting edge data
Decrease publication bias
Pulse of the community
Currency
Low-cost
Grey Literature
Limitations Lack of peer review or quality control
Disorganized
Varied formats
Agenda of mission-based organizationalpublications
Currency
INCORPORATING GREY LITERATURE
Answering Drug information Questions
Search Triad
PubMed
GoogleGoogle Scholar
Focused Review Literature Search
Focused Specialty Resource Search
What is the role of triple antithrombotic therapy?
-Guidelines-Reviews-Trials
-Protocols-Guidelines-Reports (AHRQ)
-Guidelines-Reviews-Trials
•UptoDate•DynaMed•-Pharmacist’sLetter
•Known Guidelines(CHEST, ACC/AHA)
Search Triad
PubMed Google Scholar Google
•Precision search•Controlled vocabulary•Extensive filters
•Known journal index•Grey literature access
•Search flexibility•Natural vocabulary•Full-text search
•Broad literaturecoverage•Limited advanced search•More grey literature access
•Search flexibility•Natural vocabulary•Full-text search
•Questionable sources•Limited advanced search•Extensive grey literature access
PubMed vs. Google Scholar
0%
5%
10%
15%
20%
25%
RelevantArticles
Precision Full-Text Link
PubMed
Google Scholar
P<0.001
P=0.07
P<0.001
Shariff SZ, et al. J Med Internet Res 2013;15(8):e164
© American College of Clinical Pharmacy 5
PubMed vs. Google Scholar
62%
64%
66%
68%
70%
72%
74%
76%
78%
80%
82%
Relevant Hits
PubMed
GoogleScholar
0
5
10
15
20
25
30
35
40
# ofcitations
JournalImpact
Nourbakhse E, et al. Health Info Libr J 2012;29(3):214-22.
P<0.0001
P=0.036
P=0.116
PubMed vs. Google Scholar
0%
10%
20%
30%
40%
50%
60%
70%
80%
Relevant Hits Full-text Precision
PubMed
Google Scholar
Anders ME, et al. Respir Care 2010;55(5):578-83
P<0.001
P=0.87
P=0.44
Google Power Searching
Maximizing Google search features to findrelevant drug information Primary literature, review literature, grey literature
Advanced Search
Search operators
Review top 50-100 hits
Google Power Searching
Filetype: Find articles of specific file types
Example: filetype:pdf
filetype:doc
filetype:ppt
Google Power Searching
Site: Find content from specific sites
Example: Site:.org
Site:.gov
Site:.edu
Site: accp.com
Google Power Searching
Intitle: and allintitle: Narrow search findings to title only
Example: Intitle: therapeutic interchange
allintitle:ondansetron safety pregnancy nausea
© American College of Clinical Pharmacy 6
Google Power Searching
Related: Finds websites with similar content
Related:cdc.gov
Related:cebm.net
Google Power Searching
Other Tools “Word” – turns off spell check and synonym
search
“Search phrase” – forces specific order of words "bulk drug storage" expiration
- to eliminate a word from search results “Triple antithrombotic therapy” -”atrial fibrillation”
Case
How should vancomycin be dosed for sepsisin patients on dialysis?
filetype:pdf vancomycin sepsis dialysis
Case
Does ginger increase the risk of bleeding inpatients taking antiplatelet or anticoagulantdrugs?
Site:.gov ginger “bleeding” -ulcer
© American College of Clinical Pharmacy 7
Case
http://www.powersearchingwithgoogle.com/
Grey Literature
Resources About Grey Literature Grey Literature Report (www.greylit.org)
Grey Matters (www.cadth.ca/resources/finding-evidence/grey-matters-practical-search-tool-evidence-based-medicine)
OpenGrey (www.opengrey.eu/)
GreyNet International (www.greynet.org/)
Philip J. Gregory, PharmD, MS, FACN
Director, Center for Drug Information & Evidence-Based Practice
Creighton University
© American College of Clinical Pharmacy 8
When Time Matters: Innovative Tools and Techniques to Evaluate the Quality of A Clinical Trial
Quickly and Efficiently ‐ Selected References
Melissa M. Blair, PharmD, BCPS, FCCP, FASHP [email protected]
Practice References: Translating Research Into Practice (TRIP) ‐ search engine for high‐quality evidence
www.tripdatabase.com Essential Evidence ‐ EBM summaries of over 13,000 topics
www.essentialevidenceplus.com Cochrane Library ‐ systematic reviews
www.cochrane.org ACP Journal Club ‐ trial summaries
annals.org/journalclub.aspx BMJ Clinical Evidence ‐ systematic reviews
www.clinicalevidence.com/x/index.html Dynamed ‐ EBM summaries of drug therapy, diseases
www.dynamed.com Pharmacist's Letter ‐ EBM summaries of drug therapy
www.pharmacistsletter.com Medical Letter ‐ EBM summaries of drug therapy
www.medicalletter.org PURLs/FPIN (Priority Updates from the Research Literature Surveillance system/Family Physicians Inquiries Network) ‐ trial summaries and monthly journal
www.fpin.org/purls‐info/ Evidence‐Based Medicine References: Center for Information Mastery (Tufts University) ‐ resources, worksheets
medicine.tufts.edu/Education/Academic‐Departments/Clinical‐Departments/Family‐Medicine/Center‐for‐Information‐Mastery
Centre for Evidence‐Based Medicine (CEBM) ‐ resources, teaching tools, worksheets
www.cebm.net User's Guide to the Medical Literature ‐ articles on how to evaluate different trial types
jamaevidence.mhmedical.com/book.aspx?bookID=847 ‐ compiled book for sale
www.hopkinsmedicine.org/gim/training/Osler/osler_Jama_Steps.html ‐ links to all articles Practice‐Based Journal Clubs: iForumRx ‐ Ambulatory Care
www.iforumrx.org Pharmacist's Letter ‐ Part of Preceptor Toolbox
www.pharmacistsletter.com Hospital Pharmacy
www.thomasland.com/HPJ_journalclub.html
© American College of Clinical Pharmacy 9